EBITDA growth, dividend hikes and strong FCF as gas compression demand boosts margins—see valuation, risks & upside.

So, in part owing to less attention paid to the trillion-dollar league (27.6% allocation vs. IVV's 38.3%), AVUS has an ...

The S&P 500 hit another all-time high but showed signs of fatigue, with momentum waning and technical cracks emerging. Learn ...

HIO trades at a 6.23% discount to NAV yet remains expensive relative to its 10-year historical range and recent performance.

Reliability risks are spreading across much of the US bulk power system driven by soaring peak demand forecasts and lagging ...

Realty Income's debt-to-EBITDA ratio is currently around 5.4x. For an A-rated REIT, that's acceptable—not concerning, but not ...

Silver and gold volatility reached the 99th percentile, with SLV IV at 110 and GLD IV at 42.5, creating high premiums. Read ...

Q4 results: revenue growth from dealer inventory normalization and share gains; 2026 demand subdued but rebound could lift stock 37%.

Rotation into small caps in 2026 is expected to benefit high-quality BDCs like Ares Capital (ARCC) and Main Street Capital ...

Since its IPO of 2014, Arista Networks (ANET) has returned an astonishing 37% CAGR, and that figure has been at 66% in the ...

For advisors constructing income-focused portfolios, understanding after-tax yield is critical to managing client outcomes.

Regeneron Pharmaceuticals, Inc. targets double-digit 2026 growth via Dupixent expansion and fewer Eylea headwinds. Check out ...